s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
News

Why Verizon stock is trading lower today

July 22, 2024 George Levine No comments yet

Verizon Communications (NYSE: VZ) shares are trading lower after the company reported second-quarter financial results, in which its revenue results were worse than expected.

What Happened: Before the market opened on Monday, Verizon reported its financial metrics for the second quarter of 2024.

ReportedEstimateYoY
Total Operating Revenue$32.8 billion$33.063 billion+0.6% from Q2 2023
Adjusted EPS$1.15inline$1.21 in Q2 2023

Verizon’s second quarter 2024 adjusted EPS results were inline with analyst estimates and were down from $1.21 during the same period last year.

The company’s second quarter 2024 total operating revenue results were below the consensus estimate, but higher 0.6% from the same period last year. Verizon attributed the growth in revenue to an increase in service and other revenue, which was offset by a decrease in wireless equipment revenue due to lower upgrade volumes.

Verizon’s revenue miss is the reason for the stock moving lower today, as the company didn’t perform as well as Wall Street expected.

“The sequential and year over year improvements in the second quarter were a reflection of operational excellence and the moves we made to bring choice, value and control to our customers’ lives,” said Verizon Chairman and CEO Hans Vestberg.

“The sequential and year over year improvements in the second quarter were a reflection of operational excellence and the moves we made to bring choice, value and control to our customers’ lives.”

– Verizon Chairman and CEO Hans Vestberg

Despite the revenue miss, Verizon said it remains on track to achieve its full-year 2024 financial guidance. The company expects 2024 total wireless service revenue growth of 2 to 3.5 percent and adjusted EPS of $4.50 to $4.70.

Verizon was trading 5.92% lower to $39.16 at the time of writing. The stock has a 52-week high of $43.42 and a 52-week low of $30.14.

  • Earnings

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

NLS Pharmaceutics and Kadimastem Move Closer to Merger Approval

January 31, 2025 Elisa Clay No comments yet

NLS Pharmaceutics (Nasdaq: NLSP) and Kadimastem (TASE: KDST) have reached a key milestone in their planned merger after Kadimastem’s shareholders approved the deal in a special general meeting. The merger aims to create a Nasdaq-listed biotechnology company with a strong portfolio of treatments for neurodegenerative diseases and diabetes. NLS is now preparing to hold its […]

Featured, News, Trade Ideas

Nukkleus Shares Surge 60% Amid Investor Optimism

January 17, 2025 Elisa Clay No comments yet

Nukkleus Inc. (NASDAQ: NUKK) saw its stock skyrocket by 60% during today’s trading session, marking a significant uptick in investor interest and market activity. The surge comes amid heightened speculation about the company’s growth prospects and potential strategic moves. While no major announcements were made by the company, the sharp increase in share price suggests […]

Featured, News, Trade Ideas

Inspira Technologies Ramps Up Production Readiness Amid hMPV Outbreak

January 10, 2025 Elisa Clay No comments yet

Inspira Technologies (Nasdaq: IINN), a leader in life-support technology innovation, has announced preparations for a potential production increase of its INSPIRA ART100 device. This proactive step comes in response to a recent outbreak of human metapneumovirus (hMPV) in China, which has brought renewed attention to the global need for advanced respiratory care solutions. The company […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.